Subcutaneous administration of epidermal growth factor: A true treatment option in case of postoperative liver failure?

International Journal of Surgery

Volumn 7, Issue 3, 2009, Pages 200-205

  Glanemann, Matthias ^a   Shi, Baomin ^a,b   El Zidy, Nadja ^a   Gaebelein, Gereon ^a   Kronbach, Zienab ^a   Neuhaus, Peter ^a   Nussler, Andreas K ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Epidermal growth factor (EGF); Liver; Liver insufficiency; Organ failure; Partial hepatectomy

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; LIVER RESECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CYCLIN D1; EPIDERMAL GROWTH FACTOR; HEPATECTOMY; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; KI-67 ANTIGEN; LIVER FAILURE; LIVER REGENERATION; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; SURVIVAL RATE;

EID: 67349264554     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2009.03.004     Document Type: Article

References (40)

1. Azoulay D., Castaing D., Krissat J., et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured livers. Ann Surg 232 (2000) 665-672
2. Tucker O.N., and Heaton N. The 'small for size' liver syndrome. Curr Opin Crit Care 11 (2005) 150-155
3. Schemmer P., Mehrabi A., Friess H., et al. Living related liver transplantation: the ultimate technique to expand the donor pool?. Transplantation 80 Suppl. 1 (2005) S138-S141
4. Fausto N. Liver regeneration. J Hepatol 32 S1 (2000) 19-31
5. Kountouras J., Boura P., and Lygidakis N.J. Liver regeneration after hepatectomy. Hepato-Gastroenterology 48 (2001) 556-562
6. Magnall D., Bird N.C., and Majeed A.W. The molecular physiology of liver regeneration following partial hepatectomy. Liver 23 (2003) 124-138
7. Marti U., Burwen S.J., and Jones A.L. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 9 (1989) 126-138
8. Vesey D.A., Selden A.C., Woodman A.C., and Hodgson H.J. Effect of in vivo administration of an antibody to epidermal growth factor on the rapid increase in DNA synthesis induced by partial hepatectomy in the rat. Gut 33 (1992) 831-835
9. Kiso S., Kawata S., Tamura S., et al. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology 22 (1995) 1584-1590
10. Jones Jr. D.E., Tran-Patterson R., Cui D.M., Davin D., Estell K.P., and Miller D.M. Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am J Physiol 268 (1995) G872-G878
11. Johansson S., and Andersson G. Similar induction of the hepatic EGF receptor in vivo by EGF and partial hepatectomy. Biochem Biophys Res Commun 166 (1990) 661-666
12. Blanc P., Etienne H., Daujat M., et al. Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology 102 (1992) 1340-1350
13. Oguey D., Marti U., and Reichen J. Epidermal growth factor receptor in chronic bile duct obstructed rats: implications for maintenance of hepatocellular mass. Eur J Cell Biol 59 (1992) 187-195
14. Kiso S., Kawata S., Tamura S., et al. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 124 (2003) 701-707
15. Khai N.C., Takahashi T., Ushikoshi H., et al. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF. J Hepatol 44 (2006) 1046-1054
16. Kimura M., Moro T., Motegi H., et al. In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats. Eur J Pharmacol 579 (2008) 357-364
17. Imai K., Hanaoka K., and Mine T. Zonal differences in effects of HGF/SF and EGF on DNA synthesis in hepatocytes at different times post-hepatectomy. Hepatol Res 27 (2003) 302-308
18. Glanemann M., Strenziok R., Kuntze R., et al. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 135 (2004) 203-214
19. Gaebelein G., Nüssler A.K., Morgott F., et al. Intrasplenic or subperitoneal hepatocyte transplantation to increase survival after surgically induced hepatic failure?. Eur Surg Res 41 (2008) 253-259
20. Noguchi S., Ohba Y., and Oka T. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinol 128 (1991) 425-431
21. Lambotte L., Saliez A., Triest S., et al. Effect of sialoadenectomy and epidermal growth factor administration on liver regeneration after partial hepatectomy. Hepatology 25 (1997) 607-612
22. Mitchell C., Nivison M., Jackson L.F., et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 280 (2005) 2562-2568
23. Caballero M.E., Berlanga J., Ramirez D., et al. Epidermal growth factor reduces multiorgan failure induced by thioacetamide. Gut 48 (2001) 34-40
24. Rasmussen T.N., Jørgensen P.E., Almdal T., Kirkegaard P., and Olsen P.S. Stimulatory effect of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Scand J Gastroenterol 27 (1992) 372-374
25. Ito N., Kawata S., Tamura S., et al. Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. Biochem Biophys Res Commun 198 (1994) 25-31
26. Lai H.S., Chung Y.C., Chen W.J., and Chen K.M. Rat liver regeneration after partial hepatectomy: effects of insulin, glucagon and epidermal growth factor. J Formos Med Assoc 91 (1992) 685-690
27. Hashimoto M., Kothary P.C., Eckhauser F.E., and Raper S.E. Treatment of cirrhotic rats with epidermal growth factor and insulin accelerates liver DNA synthesis after partial hepatectomy. J Gastroenterol Hepatol 13 (1998) 1259-1265
28. Konturek S.J., Dembinski A., Warzecha Z., Brzozowski T., and Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 94 (1988) 1300-1307
29. Juhl C.O., Vinter-Jensen L., Jensen L.S., Nexø E., Djurhuus J.C., and Dajani E.Z. Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs. Dig Dis Sci 39 (1994) 2671-2678
30. Brzozowski T., Konturek P.C., Konturek S.J., Brzozowska I., Kwiecien S., and Hahn E.G. Involvement of ornithine decarboxylase and polyamines in epidermal growth factor-induced recovery of gastric mucosa from gastric lesions provoked by stress. Regul Pept 74 (1998) 73-84
31. Chaet M.S., Arya G., Ziegler M.M., and Warner B.W. Epidermal growth factor enhances intestinal adaptation after massive small bowel resection. J Pediatr Surg 29 (1994) 1035-1038
32. Ribbons K.A., Howarth G.S., Davey K.B., George-Nascimento C., and Read L.C. Subcutaneous but not intraluminal epidermal growth factor stimulates colonic growth in normal adult rats. Growth Factors 10 (1994) 153-162
33. Tørring N., Jensen L.V., Wen J.G., Sørensen F.B., Djurhuus J.C., and Nexø E. Chronic treatment with epidermal growth factor induces growth of the rat ventral prostate. Scand J Urol Nephrol 35 (2001) 339-344
34. Ribbons K.A., Howarth G.S., Ford W.D., George-Nascimento C., Bourne A.J., and Read L.C. Effects of epidermal growth factor administration on repair of acetic acid-induced colonic ulcerations in rats. Growth Factors 14 (1997) 89-101
35. Bashir O., Fitzgerald A.J., Berlanga-Acosta J., Playford R.J., and Goodlad R.A. Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice. Clin Sci 105 (2003) 323-330
36. Ciardiello F., and Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 358 (2008) 1160-1174
37. Martins P.A., Theruvath T.P., and Neuhaus P. Rodent models of partial hepatectomies. Liver Int 28 (2008) 3-11
38. Natarajan A., Wagner B., and Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci U S A 104 (2007) 17081-17086
39. Dahmen U., Hall C.A., Madrahimov N., Milekhin V., and Dirsch O. Regulation of hepatic microcirculation in stepwise liver resection. Acta Gastroenterol Belg 70 (2007) 345-351
40. Bucher N.L., and Swaffield M.N. The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excited. Cancer Re 24 (1964) 1611-1625